Unusual expansion of CD3+CD56+ natural killer T-like cells in peripheral blood after anticytokine treatment for graft-versus-host disease: A case report. Issue 38 (September 2018)
- Record Type:
- Journal Article
- Title:
- Unusual expansion of CD3+CD56+ natural killer T-like cells in peripheral blood after anticytokine treatment for graft-versus-host disease: A case report. Issue 38 (September 2018)
- Main Title:
- Unusual expansion of CD3+CD56+ natural killer T-like cells in peripheral blood after anticytokine treatment for graft-versus-host disease
- Authors:
- Sheng, Lixia
Fu, Huarui
Tan, Yamin
Hu, Yongxian
Mu, Qitian
Luo, Yi
Shi, Jianmin
Cai, Zhen
Ouyang, Guifang
Huang, He - Other Names:
- NA. section editor.
- Abstract:
- Abstract: Rationale: Basiliximab and etanercept have achieved promising responses in steroid-refractory graft versus host disease (SR-GVHD). However, the in vivo immune changes following the treatment have not been elucidated. Patient concerns: A 14-year-old boy presented with skin rash and diarrhea 20 days after haploidentical hemotopoietic stem cell transplantation. Diagnoses: We made the diagnose of grade 3 acute GVHD with skin and gastrointestinal involvement. Interventions: After the failure of the first-line treatment with methylprednisolone, combined anti-cytokine therapies with basiliximab and etanercept were prescibed. Outcomes: He achieved complete remission by basiliximab and etanercept. Furthermore, we detected that donor CD3 + CD56 + Natural killer T(NKT)-like cells expanded gradually after the period of lymphocytopenia caused by GVHD and anti-cytokine therapy. The expansion of NKT-like cells was in association with high serum IFN-γ. NKT-like cells showed preferred proliferation in response to IFN-γ and potent cytotoxicity against leukemia cells. The expansion persisted > 2 years and the patient had a leukemia-free survival of 66 months. Lessons: Our case indicated that combined anti-cytokine treatment may reset the immune system and cause NKT-like cells to exhibit a predilection for expansion.
- Is Part Of:
- Medicine. Volume 97:Issue 38(2018)
- Journal:
- Medicine
- Issue:
- Volume 97:Issue 38(2018)
- Issue Display:
- Volume 97, Issue 38 (2018)
- Year:
- 2018
- Volume:
- 97
- Issue:
- 38
- Issue Sort Value:
- 2018-0097-0038-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-09
- Subjects:
- basiliximab -- etanercept -- interferon gamma -- natural killer T cells -- steroid-refractory acute GVHD
Medicine -- Periodicals
Medicine -- Periodicals
Médecine -- Périodiques
Geneeskunde
Medicine
Periodicals
Periodicals
610.5 - Journal URLs:
- http://journals.lww.com/md-journal/pages/default.aspx ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=toc&D=ovft&MODE=ovid&NEWS=N&AN=00002060-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MD.0000000000012429 ↗
- Languages:
- English
- ISSNs:
- 0025-7974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5534.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9126.xml